Inhibition of aldose reductase by dietary antioxidant curcumin: Mechanism of inhibition, specificity and significance

被引：75

作者：

Muthenna, P. ^{[1
]}

Suryanarayana, P. ^{[1
]}

Gunda, Shravan K. ^{[2
]}

Petrash, J. Mark ^{[3
]}

Reddy, G. Bhanuprakash ^{[1
]}

机构：

[1] Jamai Osmania, Div Biochem, Natl Inst Nutr, Hyderabad 500604, Andhra Pradesh, India

[2] Osmania Univ, Bioinformat Ctr, Hyderabad 500007, Andhra Pradesh, India

[3] Univ Colorado, Rocky Mt Lions Eye Inst, Dept Ophthalmol, Aurora, CO USA

来源：

FEBS LETTERS | 2009年 / 583卷 / 22期

关键词：

Aldo-keto reductase; ALR2; AKR1B10; Curcumin; Sorbitol; HUMAN-TISSUES; ALDEHYDE; SORBITOL; END;

D O I：

10.1016/j.febslet.2009.10.042

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Accumulation of intracellular sorbitol due to increased aldose reductase (ALR2) activity has been implicated in the development of various secondary complications of diabetes. In this study we show that curcumin inhibits ALR2 with an IC50 of 10 mu M in a non-competitive manner, but is a poor inhibitor of closely-related members of the aldo-keto reductase superfamily, particularly aldehyde reductase. Results from molecular docking studies are consistent with the pattern of inhibition of ALR2 by curcumin and its specificity. Moreover, curcumin is able to suppress sorbitol accumulation in human erythrocytes under high glucose conditions, demonstrating an in vivo potential of curcumin to prevent sorbitol accumulation. These results suggest that curcumin holds promise as an agent to prevent or treat diabetic complications. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

引用

页码：3637 / 3642

页数：6

共 33 条

[21] PETRASH JM, 1992, J BIOL CHEM, V267, P24833
[22] Aldose reductase inhibitors: The end of an era or the need for different trial designs?
Pfeifer, MA
Schumer, MP
Gelber, DA
[J]. DIABETES, 1997, 46 : S82 - S89
[23] Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions
Premanand, Chinnaraj
Rema, Mohan
Sameer, Mahmood Z.
Sujatha, Mohan
Balasubramanyam, Muthusamy
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (05) : 2179 - 2184
[24] ALDOSE REDUCTASE INHIBITORS AND DIABETIC COMPLICATIONS
RASKIN, P
ROSENSTOCK, J
[J]. AMERICAN JOURNAL OF MEDICINE, 1987, 83 (02) : 298 - 306
[25] Reddy GB, 2008, MOL VIS, V14, P593
[26] Aldo-keto reductases from the AKR1B subfamily: Retinoid specificity and control of cellular retinoic acid levels
Ruiz, F. Xavier
Gallego, Oriol
Ardevol, Albert
Moro, Armando
Dominguez, Marta
Alvarez, Susana
Alvarez, Rosana
de Lera, Angel R.
Rovira, Carme
Fita, Ignacio
Pares, Xavier
Farres, Jaume
[J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) : 171 - 177
[27] Saraswat M, 2008, ASIA PAC J CLIN NUTR, V17, P558
[28] Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes
Spite, Matthew
Baba, Shahid P.
Ahmed, Yonis
Barski, Oleg A.
Nijhawan, Kanchan
Petrash, J. Mark
Bhatnagar, Aruni
Srivastava, Sanjay
[J]. BIOCHEMICAL JOURNAL, 2007, 405 : 95 - 105
[29] SUSCEPTIBILITY OF ALDEHYDE AND ALDOSE REDUCTASES OF HUMAN-TISSUES TO ALDOSE REDUCTASE INHIBITORS
SRIVASTAVA, SK
PETRASH, JM
SADANA, IJ
ANSARI, NH
PARTRIDGE, CA
[J]. CURRENT EYE RESEARCH, 1982, 2 (06) : 407 - 410
[30] Detailed analysis of scoring functions for virtual screening
Stahl, M
Rarey, M
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (07) : 1035 - 1042

← 1 2 3 4 →